Hideki Muranaka

510 total citations
13 papers, 416 citations indexed

About

Hideki Muranaka is a scholar working on Psychiatry and Mental health, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Hideki Muranaka has authored 13 papers receiving a total of 416 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Psychiatry and Mental health, 5 papers in Molecular Biology and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Hideki Muranaka's work include Epilepsy research and treatment (8 papers), Ion channel regulation and function (3 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Hideki Muranaka is often cited by papers focused on Epilepsy research and treatment (8 papers), Ion channel regulation and function (3 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Hideki Muranaka collaborates with scholars based in Japan. Hideki Muranaka's co-authors include Sunao Kaneko, Goryu Fukuma, Shinichi Hirose, Akihisa Mitsudome, Hiromi Iwata, Toshio Hanai, Kazumaru Wada, Takahito Inoue, Hidetaka Akiyoshi and Sawa Yasumoto and has published in prestigious journals such as Annals of Neurology, Epilepsia and Brain and Development.

In The Last Decade

Hideki Muranaka

12 papers receiving 406 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hideki Muranaka Japan	6	275	218	158	133	86	13	416
Victoria Rodriguez‐Casero Australia	5	241 0.9×	142 0.7×	100 0.6×	64 0.5×	177 2.1×	7	380
Daniela Buti Italy	6	331 1.2×	112 0.5×	78 0.5×	136 1.0×	179 2.1×	8	428
Celina von Stülpnagel Germany	13	228 0.8×	99 0.5×	68 0.4×	137 1.0×	82 1.0×	25	381
R. Sebastianelli Italy	5	264 1.0×	134 0.6×	96 0.6×	93 0.7×	142 1.7×	6	333
Kazumasa Otani Japan	12	190 0.7×	89 0.4×	60 0.4×	198 1.5×	70 0.8×	25	402
Rachael Ellis United Kingdom	6	312 1.1×	133 0.6×	87 0.6×	170 1.3×	187 2.2×	6	440
Joanne Tracey Dean Australia	3	203 0.7×	135 0.6×	106 0.7×	45 0.3×	119 1.4×	3	310
Barbara Podestà Italy	5	159 0.6×	77 0.4×	52 0.3×	94 0.7×	90 1.0×	7	252
Melanie Bonner United States	6	148 0.5×	108 0.5×	61 0.4×	55 0.4×	76 0.9×	9	249
Yukiko Mogami Japan	11	138 0.5×	86 0.4×	31 0.2×	92 0.7×	52 0.6×	37	342

Countries citing papers authored by Hideki Muranaka

Since Specialization

Citations

This map shows the geographic impact of Hideki Muranaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideki Muranaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideki Muranaka more than expected).

Fields of papers citing papers by Hideki Muranaka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideki Muranaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideki Muranaka. The network helps show where Hideki Muranaka may publish in the future.

Co-authorship network of co-authors of Hideki Muranaka

This figure shows the co-authorship network connecting the top 25 collaborators of Hideki Muranaka. A scholar is included among the top collaborators of Hideki Muranaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideki Muranaka. Hideki Muranaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Fukuma, Goryu, Hirokazu Oguni, Yukiyoshi Shirasaka, et al.. (2004). Mutations of Neuronal Voltage‐gated Na⁺ Channel α1 Subunit Gene SCN1A in Core Severe Myoclonic Epilepsy in Infancy (SMEI) and in Borderline SMEI (SMEB). Epilepsia. 45(2). 140–148. 161 indexed citations

Muranaka, Hideki, et al.. (2001). [Intranasal midazolam for prevention of status epilepticus].. PubMed. 33(3). 283–4. 2 indexed citations

Muranaka, Hideki, et al.. (2001). Visual Symptoms in Epilepsy and Migraine: Localization and Patterns. Epilepsia. 42(1). 62–66. 11 indexed citations

Hirose, Shinichi, Hidetaka Akiyoshi, Goryu Fukuma, et al.. (2000). A novel mutation of KCNQ3 (c.925T→C) in a Japanese family with benign familial neonatal convulsions. Annals of Neurology. 47(6). 822–826. 3 indexed citations

Hirose, Shinichi, Hidetaka Akiyoshi, Goryu Fukuma, et al.. (2000). A novel mutation of KCNQ3 (c.925T-->C) in a Japanese family with benign familial neonatal convulsions.. PubMed. 47(6). 822–6. 82 indexed citations

Hirose, Shinichi, Hidetaka Akiyoshi, Goryu Fukuma, et al.. (2000). A novel mutation ofKCNQ3 (c.925T?C) in a Japanese family with benign familial neonatal convulsions. Annals of Neurology. 47(6). 822–826. 71 indexed citations

Kimura, Yuko, et al.. (2000). [Recurrent tongue biting due to hypnic myoclonia in infancy].. PubMed. 32(4). 358–62. 2 indexed citations

Muranaka, Hideki, et al.. (1998). Prognostic Value of Elementary Visual Hallucinations in Patients with Occipital Lobe Epilepsy. Epilepsia. 39(S5). 67–67. 1 indexed citations

Muranaka, Hideki, et al.. (1997). Congenital familial myopathy with type 2 fiber hypoplasia and type 1 fiber predominance. Brain and Development. 19(5). 362–365. 3 indexed citations

10.

Muranaka, Hideki, et al.. (1995). Persistent chorea following cardiac surgery for congenital heart disease. Pediatrics International. 37(3). 409–412. 3 indexed citations

11.

Muranaka, Hideki, et al.. (1995). Evaluation of cefpodoxime proxetil dry syrup in pediatric patients with various infections.. PubMed. 7 Suppl 4. 127–30. 1 indexed citations

12.

Kondo, Tsuyoshi, Sunao Kaneko, Koichi Otani, et al.. (1992). Associations Between Risk Factors for Valproate Hepatotoxicity and Altered Valproate Metabolism. Epilepsia. 33(1). 172–177. 55 indexed citations

13.

Ishida, Masayuki, Sunao Kaneko, Takayuki Hirano, et al.. (1992). Is 2‐Propyl‐4‐Pentenoic Acid, a Hepatotoxic Metabolite of Valproate, Responsible for Valproate‐Induced Hyperammonemia?. Epilepsia. 33(3). 550–554. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact